19-40395697-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_181882.3(PRX):​c.2655T>C​(p.Pro885Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.527 in 1,613,490 control chromosomes in the GnomAD database, including 230,372 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 27124 hom., cov: 33)
Exomes 𝑓: 0.52 ( 203248 hom. )

Consequence

PRX
NM_181882.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -3.17

Publications

23 publications found
Variant links:
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]
PRX Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease type 4F
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • Charcot-Marie-Tooth disease type 3
    Inheritance: AD, AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 19-40395697-A-G is Benign according to our data. Variant chr19-40395697-A-G is described in ClinVar as Benign. ClinVar VariationId is 130049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.17 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.793 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRXNM_181882.3 linkc.2655T>C p.Pro885Pro synonymous_variant Exon 7 of 7 ENST00000324001.8 NP_870998.2 Q9BXM0-1
PRXNM_001411127.1 linkc.2940T>C p.Pro980Pro synonymous_variant Exon 7 of 7 NP_001398056.1
PRXXM_017027047.2 linkc.2553T>C p.Pro851Pro synonymous_variant Exon 4 of 4 XP_016882536.1
PRXNM_020956.2 linkc.*2860T>C 3_prime_UTR_variant Exon 6 of 6 NP_066007.1 Q9BXM0-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRXENST00000324001.8 linkc.2655T>C p.Pro885Pro synonymous_variant Exon 7 of 7 1 NM_181882.3 ENSP00000326018.6 Q9BXM0-1

Frequencies

GnomAD3 genomes
AF:
0.579
AC:
87698
AN:
151590
Hom.:
27082
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.800
Gnomad AMI
AF:
0.652
Gnomad AMR
AF:
0.517
Gnomad ASJ
AF:
0.446
Gnomad EAS
AF:
0.203
Gnomad SAS
AF:
0.467
Gnomad FIN
AF:
0.445
Gnomad MID
AF:
0.452
Gnomad NFE
AF:
0.522
Gnomad OTH
AF:
0.552
GnomAD2 exomes
AF:
0.500
AC:
125454
AN:
250912
AF XY:
0.495
show subpopulations
Gnomad AFR exome
AF:
0.805
Gnomad AMR exome
AF:
0.519
Gnomad ASJ exome
AF:
0.470
Gnomad EAS exome
AF:
0.195
Gnomad FIN exome
AF:
0.454
Gnomad NFE exome
AF:
0.519
Gnomad OTH exome
AF:
0.495
GnomAD4 exome
AF:
0.521
AC:
762106
AN:
1461782
Hom.:
203248
Cov.:
94
AF XY:
0.519
AC XY:
377289
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.801
AC:
26818
AN:
33478
American (AMR)
AF:
0.519
AC:
23200
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.462
AC:
12087
AN:
26136
East Asian (EAS)
AF:
0.184
AC:
7305
AN:
39696
South Asian (SAS)
AF:
0.472
AC:
40681
AN:
86254
European-Finnish (FIN)
AF:
0.450
AC:
24038
AN:
53404
Middle Eastern (MID)
AF:
0.450
AC:
2586
AN:
5748
European-Non Finnish (NFE)
AF:
0.534
AC:
594334
AN:
1111962
Other (OTH)
AF:
0.514
AC:
31057
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
28873
57746
86618
115491
144364
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16936
33872
50808
67744
84680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.579
AC:
87787
AN:
151708
Hom.:
27124
Cov.:
33
AF XY:
0.569
AC XY:
42172
AN XY:
74120
show subpopulations
African (AFR)
AF:
0.800
AC:
33104
AN:
41372
American (AMR)
AF:
0.517
AC:
7894
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.446
AC:
1548
AN:
3468
East Asian (EAS)
AF:
0.201
AC:
1035
AN:
5140
South Asian (SAS)
AF:
0.467
AC:
2251
AN:
4820
European-Finnish (FIN)
AF:
0.445
AC:
4671
AN:
10500
Middle Eastern (MID)
AF:
0.452
AC:
132
AN:
292
European-Non Finnish (NFE)
AF:
0.522
AC:
35412
AN:
67836
Other (OTH)
AF:
0.544
AC:
1151
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1795
3589
5384
7178
8973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.528
Hom.:
30767
Bravo
AF:
0.596
Asia WGS
AF:
0.337
AC:
1173
AN:
3478
EpiCase
AF:
0.509
EpiControl
AF:
0.522

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 4F Benign:3
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Apr 25, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dejerine-Sottas disease Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 4 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.14
DANN
Benign
0.31
PhyloP100
-3.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs268672; hg19: chr19-40901604; COSMIC: COSV52530165; API